Yu et al. reported the use of a four-protein panel (MMP1, KNG1, ANXA2, and HSPA5) to evaluate cancer progression risk and early disease detection of oral squamous cell carcinoma (OSCC) using liquid chromatography–multiple-reaction-monitoring–mass spectrometry. The gene discussed is ANXA2; the disease is cancer.